Functional Genomic Screening Independently Identifies CUL3 as a Mediator of Vemurafenib Resistance via Src-Rac1 Signaling AxisMarion Vanneste, Michael D. Henry|Frontiers in Oncology|2020Cited by 60
High content screening identifies monensin as an EMT-selective cytotoxic compoundMarion Vanneste, Michael D. Henry|Scientific Reports|2019Cited by 45
The anti-cancer efficacy of a novel phenothiazine derivative is independent of dopamine and serotonin receptor inhibitionMarion Vanneste, Michael D. Henry|Frontiers in Oncology|2023Cited by 7